CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases

References

• Holland HD. The oxygenation of the atmosphere and oceans. Phil Trans R Soc B. 2006;361(1470):903–915. doi:10.1098/rstb.2006.1838.
   PubMed Web of Science ®Google Scholar
• Cantine MD, Fournier GP. Environmental Adaptation from the Origin of Life to the Last Universal Common Ancestor. Orig Life Evol Biosph. 2018;48(1):35–54. doi:10.1007/s11084-017-9542-5.
   PubMed Web of Science ®Google Scholar
• Joyce GF. The antiquity of RNA-based evolution. Nature. 2002;418(6894):214–221. doi:10.1038/418214a.
   PubMed Web of Science ®Google Scholar
• Olson SL, Schwieterman EW, Reinhard CT, et al. Earth: Atmospheric Evolution of a Habitable Planet. In Deeg H, Belmonte J (editors) Handbook of Exoplanets. Cham: Springer; 2018. pp 1–37. doi:10.1007/978-3-319-30648-3_189-1.
   Google Scholar
• Planavsky NJ, Asael D, Hofmann A, et al. Evidence for oxygenic photosynthesis half a billion years before the Great Oxidation Event. Nature Geosci. 2014;7(4):283. doi:10.1038/ngeo2122.
   Web of Science ®Google Scholar
• Kasting JF, Siefert JL. Life and the evolution of Earth’s atmosphere. Science (80-). 2002;296(5570):1066–1068. doi:10.1126/science.1071184.
   Web of Science ®Google Scholar
• Knoll AH, Javaux EJ, Hewitt D, et al. Eukaryotic organisms in Proterozoic oceans. Phil Trans R Soc B. 2006;361(1470):1023–1038. doi:10.1098/rstb.2006.1843.
   PubMed Web of Science ®Google Scholar
• Sessions AL, Doughty DM, Welander PV, et al. The Continuing Puzzle of the Great Oxidation Event. Curr Biol. 2009;19(14):R567–74. doi:10.1016/j.cub.2009.05.054.
   PubMed Web of Science ®Google Scholar
• Gross J, Bhattacharya D. Uniting sex and eukaryote origin in an emerging oxygenic world. Biol Direct. 2010;5(1):53. doi:10.1186/1745-6150-5-53.
   PubMedGoogle Scholar
• Cooper GJT, Surman AJ, McIver J, et al. Miller–Urey Spark-Discharge Experiments in the Deuterium World. Angew Chem Int Ed. 2017;56(28):8079–8082. doi:10.1002/anie.201610837.
   PubMed Web of Science ®Google Scholar
• Pennazio S. Alexandr Oparin and the origin of life on Earth. Riv Biol. 2009;102(1):95–118.
   PubMedGoogle Scholar
• Miller SL. A Production of Amino Acids Under Possible Primitive Earth Conditions. Science (80-). 1953;117(3046):528–529. doi:10.1126/science.117.3046.528.
   PubMed Web of Science ®Google Scholar
• Gilbert W. Origin of life: The RNA world. Nature. 1986;319(6055):618. doi:10.1038/319618a0.
   PubMed Web of Science ®Google Scholar
• Joyce GF. RNA evolution and the origins of life. Nature. 1989;338(6212):217. doi:10.1038/338217a0.
   PubMed Web of Science ®Google Scholar
• Weiss MC, Sousa FL, Mrnjavac N, et al. The physiology and habitat of the last universal common ancestor. Nat Microbiol. 2016;1(9):16116. doi:10.1038/nmicrobiol.2016.116.
   PubMed Web of Science ®Google Scholar
• Cooper MD, Alder MN. The evolution of adaptive immune systems. Cell. 2006;124(4):815–822. doi:10.1016/j.cell.2006.02.001.
   PubMed Web of Science ®Google Scholar
• Bayersdorf R, Fruscalzo A, Catania F. Linking autoimmunity to the origin of the adaptive immune system. Evol Med Public Heal. 2018;2018(1):2–12. doi:10.1093/emph/eoy001.
   PubMedGoogle Scholar
• Burnet M. The Clonal Selection Theory of Acquired Immunity. Yale J Biol Med. 1960;32(6): 480
   Google Scholar
• Alder MN, Rogozin IB, Iyer LM, et al. Immunology: Diversity and function of adaptive immune receptors in a jawless vertebrate. Science. 2005;310(5756):1970–1973. 80-) doi:10.1126/science.1119420.
   PubMed Web of Science ®Google Scholar
• Pradeu T, Du Pasquier L. Immunological memory: What’s in a name?. Immunol Rev. 2018;283(1):7–20. doi:10.1111/imr.12652.
   PubMed Web of Science ®Google Scholar
• Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol. 2010;8(5):317–327. doi:10.1038/nrmicro2315.
   PubMed Web of Science ®Google Scholar
• Barrangou R, Marraffini LA. CRISPR-cas systems: Prokaryotes upgrade to adaptive immunity. Mol Cell. 2014;54(2):234–244. doi:10.1016/j.molcel.2014.03.011.
   PubMed Web of Science ®Google Scholar
• Xia A-L, He Q-F, Wang J-C, et al. Applications and advances of CRISPR-Cas9 in cancer immunotherapy. J Med Genet. 2018;56:4–9. doi:10.1136/jmedgenet-2018-105422.
   PubMed Web of Science ®Google Scholar
• Mahmoudian-Sani MR, Farnoosh G, Mahdavinezhad A, et al. CRISPR genome editing and its medical applications. Biotechnol Biotechnol Equip. 2018;32(2):286–292. doi:10.1080/13102818.2017.1406823.
   Web of Science ®Google Scholar
• Makarova KS, Wolf YI, Alkhnbashi OS, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015;13(11):722–736. doi:10.1038/nrmicro3569.
   PubMed Web of Science ®Google Scholar
• Ishino Y, Shinagawa H, Makino K, et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 1987;169(12):5429–5433. doi:10.1128/jb.169.12.5429-5433.1987.
   PubMed Web of Science ®Google Scholar
• Ishino Y, Krupovic M, Forterre P. History of CRISPR-Cas from encounter with a mysterious repeated sequence to genome editing technology. J Bacteriol. 2018;200(7): e00580–17 doi:10.1128/JB.00580-17.
   PubMed Web of Science ®Google Scholar
• Mojica FJ, Juez G, Rodríguez-Valera F. Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially modified PstI sites. Mol Microbiol. 1993;9(3):613–621. doi:10.1111/j.1365-2958.1993.tb01721.x.
   PubMed Web of Science ®Google Scholar
• She Q, Singh RK, Confalonieri F, et al. The complete genome of the crenarchaeon Sulfolobus solfataricus P2. Proc Natl Acad Sci. 2001;98(14):7835–7840. doi:10.1073/pnas.141222098.
   PubMed Web of Science ®Google Scholar
• Jansen R, Embden JDA, van Gaastra W, et al. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol. 2002;43(6):1565–1575. doi:10.1046/j.1365-2958.2002.02839.x.
   PubMed Web of Science ®Google Scholar
• Bolotin A, Quinquis B, Sorokin A, et al. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (Reading, Engl.). 2005;151(Pt 8):2551–2561. doi:10.1099/mic.0.28048-0.
   PubMed Web of Science ®Google Scholar
• Belkum A, Van Scherer S, Alphen L, Van, et al. Short-Sequence DNA Repeats in Prokaryotic Genomes Short-Sequence DNA Repeats in. Prokaryotic Genomes. 1998;62:275–293.
   Google Scholar
• Mojica FJM, Díez-Villaseñor C, Soria E, et al. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol Microbiol. 2000;36(1):244–246. doi:10.1046/j.1365-2958.2000.01838.x.
   PubMed Web of Science ®Google Scholar
• Mojica FJM, Díez-Villaseñor C, García-Martínez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol. 2005;60(2):174–182., doi:10.1007/s00239-004-0046-3.
   PubMed Web of Science ®Google Scholar
• Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology (Reading, Engl)..). 2005;151(Pt 3):653–663. doi:10.1099/mic.0.27437-0.
   PubMed Web of Science ®Google Scholar
• Makarova KS, Koonin EV. Annotation and Classification of CRISPR-Cas Systems. Methods Mol Biol.. 2015;1311:47–75. doi:10.1007/978-1-4939-2687-9_4.
   PubMedGoogle Scholar
• Shmakov S, Smargon A, Scott D, et al. Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol. 2017;15(3):169–182. doi:10.1038/nrmicro.2016.184.
   PubMed Web of Science ®Google Scholar
• Makarova KS, Grishin NV, Shabalina SA, et al. A putative RNA-interference-based immune system in prokaryotes: Computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct. 2006;1(1):7. doi:10.1186/1745-6150-1-7.
   PubMed Web of Science ®Google Scholar
• Marraffini LA, Sontheimer EJ. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet. 2010;11(3):181–190. doi:10.1038/nrg2749.
   PubMed Web of Science ®Google Scholar
• Barrangou R, Fremaux C, Deveau H, et al. CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes. Science. 2007;315(5819):1709–1712. 80-) doi:10.1126/science.1138140.
   PubMed Web of Science ®Google Scholar
• Alkhnbashi OS, Shah SA, Garrett RA, et al. Characterizing leader sequences of CRISPR loci. Bioinformatics. 2016;32(17):i576–85. doi:10.1093/bioinformatics/btw454.
   PubMed Web of Science ®Google Scholar
• Bult CJ, White O, Olsen GJ, et al. Complete genome sequence of the Methanogenic archaeon, Methanococcus jannaschii. Science. 1996;273(5278):1058–1073. 80-) doi:10.1126/science.273.5278.1058.
   PubMed Web of Science ®Google Scholar
• Brouns SJJ, Jore MM, Lundgren M, et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science. 2008;321(5891):960–964. doi:10.1126/science.1159689.
   PubMed Web of Science ®Google Scholar
• Díez-Villaseñor C, Guzmán NM, Almendros C, et al. CRISPR-spacer integration reporter plasmids reveal distinct genuine acquisition specificities among CRISPR-Cas I-E variants of Escherichia coli. RNA Biol. 2013;10(5):792–802. doi:10.4161/rna.24023.
   PubMed Web of Science ®Google Scholar
• Shah SA, Garrett RA. CRISPR/Cas and Cmr modules, mobility and evolution of adaptive immune systems. Res Microbiol. 2011;162(1):27–38. doi:10.1016/j.resmic.2010.09.001.
   PubMed Web of Science ®Google Scholar
• Gudbergsdottir S, Deng L, Chen Z, et al. Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers. Mol Microbiol. 2011;79(1):35–49. doi:10.1111/j.1365-2958.2010.07452.x.
   PubMed Web of Science ®Google Scholar
• Amitai G, Sorek R. CRISPR-Cas adaptation: Insights into the mechanism of action. Nat Rev Microbiol. 2016;14(2):67–76. doi:10.1038/nrmicro.2015.14.
   PubMed Web of Science ®Google Scholar
• Wiedenheft B, Zhou K, Jinek M, et al. Structural Basis for DNase Activity of a Conserved Protein Implicated in CRISPR-Mediated Genome Defense. Structure. 2009;17(6):904–912. doi:10.1016/j.str.2009.03.019.
   PubMed Web of Science ®Google Scholar
• van der Ploeg JR. Analysis of CRISPR in Streptocccus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages. Microbiology. 2009;155:1966–1976. doi:10.1099/mic.0.027508-0.
   PubMed Web of Science ®Google Scholar
• Barrangou R, Garneau JE, Labonte J, et al. Phage Response to CRISPR-Encoded Resistance in. J Bacteriol. 2008;190:1390–1369. doi:10.1128/JB.01412-07.
   PubMed Web of Science ®Google Scholar
• Mojica FJM, Díez-Villaseñor C, García-Martínez J, et al. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology (Reading, Engl.). 2009;155(Pt 3):733–740. doi:10.1099/mic.0.023960-0.
   PubMed Web of Science ®Google Scholar
• Leenay RT, Beisel CL. Deciphering, Communicating, and Engineering the CRISPR PAM. J Mol Biol. 2017;429(2):177–191. doi:10.1016/j.jmb.2016.11.024.
   PubMed Web of Science ®Google Scholar
• Hille F, Charpentier E. CRISPR-cas: Biology, mechanisms and relevance. Philos Trans R Soc B Biol Sci. 2016;371(1707): 20150496. doi:10.1098/rstb.2015.0496.
   PubMed Web of Science ®Google Scholar
• Zhang J, Rouillon C, Kerou M, et al. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell. 2012;45(3):303–313. doi:10.1016/j.molcel.2011.12.013.
   PubMed Web of Science ®Google Scholar
• Hale CR, Zhao P, Olson S, et al. RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex. Cell. 2009;139(5):945–956. doi:10.1016/j.cell.2009.07.040.
   PubMed Web of Science ®Google Scholar
• Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):1262–1278. doi:10.1016/j.cell.2014.05.010.
   PubMed Web of Science ®Google Scholar
• Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821. 80-) doi:10.1126/science.1225829.
   PubMed Web of Science ®Google Scholar
• Mali P, Yang L, Esvelt KM, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823–826. 80-) doi:10.1126/science.1232033.
   PubMed Web of Science ®Google Scholar
• Baylis F, McLeod M. First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?. Curr Gene Ther. 2017;17(4):309–319. doi:10.2174/1566523217666171121165935.
   PubMed Web of Science ®Google Scholar
• Feng X, Zhao D, Zhang X, et al. CRISPR/Cas9 Assisted Multiplex Genome Editing Technique in Escherichia coli. Biotechnol J. 2018;13(9):1700604. doi:10.1002/biot.201700604.
   Web of Science ®Google Scholar
• Xie N, Zhou Y, Sun Q, et al. Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System. Stem Cells Int. 2018;2018:1–12. doi:10.1155/2018/7834175.
   Google Scholar
• Yoshida M, Yokota E, Sakuma T, et al. Development of an integrated CRISPRi targeting Np63 for treatment of squamous cell carcinoma. Oncotarget. 2018;9(49):29220–29232. doi:10.18632/oncotarget.25678.
   PubMedGoogle Scholar
• Adli M. The CRISPR tool kit for genome editing and beyond. Nat Commun. 2018;9(1):1911. doi:10.1038/s41467-018-04252-2.
   PubMedGoogle Scholar
• Simeonov DR, Marson A. CRISPR-Based Tools in Immunity. Annu Rev Immunol. 2019;37(1):571–597. doi:10.1146/annurev-immunol-042718-041522.
   PubMedGoogle Scholar
• Parnas O, Jovanovic M, Eisenhaure TM, et al. A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks. Cell. 2015;162:675–686. doi:10.1016/j.cell.2015.06.059.
   PubMed Web of Science ®Google Scholar
• Lin J-D, Cheng C-W. Causal variants in autoimmune disease: a commentary on a recent published fine-mapping algorithm analysis in genome-wide association studies study. Ann Transl Med. 2017;5(6):151–151. doi:10.21037/atm.2017.02.26.
   PubMed Web of Science ®Google Scholar
• Farh KKH, Marson A, Zhu J, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337–343. doi:10.1038/nature13835.
   PubMed Web of Science ®Google Scholar
• Sanjana NE, Wright J, Zheng K, et al. High-resolution interrogation of functional elements in the noncoding genome. Science. 2016;353(6307):1545–1549. doi:10.1126/science.aaf7613.
   PubMed Web of Science ®Google Scholar
• Bauer DE, Kamran SC, Lessard S, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342(6155):253–257. 80-) doi:10.1126/science.1242088.
   PubMed Web of Science ®Google Scholar
• Simeonov DR, Gowen BG, Boontanrart M, Roth TL, et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature. 2017;549(7670):111–115. doi:10.1038/nature23875.
   PubMed Web of Science ®Google Scholar
• Huang H, Fang M, Jostins L, et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017;547(7662):173–178. doi:10.1038/nature22969.
   PubMed Web of Science ®Google Scholar
• Burr ML, Sparbier CE, Chan YC, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-Tumour immunity. Nature. 2017;549(7670):101–105. doi:10.1038/nature23643.
   PubMed Web of Science ®Google Scholar
• Bray C, Wright D, Haupt S, et al. Crispr/Cas mediated deletion of PTPN22 in Jurkat T cells enhances TCR signaling and production of IL-2. Front Immunol. 2018;9:1–10. doi:10.3389/fimmu.2018.02595.
   PubMed Web of Science ®Google Scholar
• Sevim H, Kocaefe YÇ, Onur MA, et al. Bone marrow derived mesenchymal stem cells ameliorate inflammatory response in an in vitro model of familial hemophagocytic lymphohistiocytosis 2. Stem Cell Res Ther. 2018;9(1):1–10. doi:10.1186/s13287-018-0941-y.
   PubMedGoogle Scholar
• Speck-Hernandez CA, Assis AF, Felicio RF, et al. Aire disruption influences the medullary thymic epithelial cell transcriptome and interaction with thymocytes. Front Immunol. 2018;9:1–15. doi:10.3389/fimmu.2018.00964.
   PubMed Web of Science ®Google Scholar
• Chang CW, Lai YS, Westin E, et al. Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting. Cell Rep. 2015;12(10):1668–1677. doi:10.1016/j.celrep.2015.08.013.
   PubMed Web of Science ®Google Scholar
• Roth TL, Puig-Saus C, Yu R, et al. Reprogramming human T cell function and specificity with non-viral genome targeting. Nature. 2018;559(7714):405–409. doi:10.1038/s41586-018-0326-5.
   PubMed Web of Science ®Google Scholar
• Huang X, Wang Y, Yan W, et al. Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient ipscs after genome editing of the sickle point mutation. Stem Cells. 2015;33(5):1470–1479. doi:10.1002/stem.1969.
   PubMed Web of Science ®Google Scholar
• Miao Z, Li Q, Zhao J, et al. Stable expression of infliximab in CRISPR/Cas9-mediated BAK1-deficient CHO cells. Biotechnol Lett. 2018;40(8):1209–1218. doi:10.1007/s10529-018-2578-4.
   PubMed Web of Science ®Google Scholar
• Safari F, Farajnia S, Arya M, et al. CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2018;40(3):201–211. doi:10.1080/08923973.2018.1437625.
   PubMed Web of Science ®Google Scholar
• Jeffries MA, Sawalha AH. Autoimmune disease in the epigenetic era: How has epigenetics changed our understanding of disease and how can we expect the field to evolve?. Expert Rev Clin Immunol. 2015;11(1):45–58. doi:10.1586/1744666X.2015.994507.
   PubMed Web of Science ®Google Scholar
• Gibson GJ, Yang M. What rheumatologists need to know about CRISPR/Cas9. Nat Rev Rheumatol. 2017;13(4):205–216. doi:10.1038/nrrheum.2017.6.
   PubMed Web of Science ®Google Scholar
• Xu X, Qi LS. A CRISPR–dCas Toolbox for Genetic Engineering and Synthetic Biology. J Mol Biol. 2019;431(1):34–47. doi:10.1016/j.jmb.2018.06.037.
   PubMed Web of Science ®Google Scholar
• Qi L, Lo A. Genetic and epigenetic control of gene expression by CRISPR-Cas systems. F1000Res. 2017;6:1–16. doi:10.12688/f1000research.11113.1.
   Google Scholar
• Esensten JH, Wofsy D, Bluestone JA. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5(10):560–565. doi:10.1038/nrrheum.2009.183.
   PubMed Web of Science ®Google Scholar
• Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015;45(2):344–355. doi:10.1002/eji.201344280.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Josefowicz S, Chaudhry A, et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. 2010;463(7282):808–812. doi:10.1038/nature08750.
   PubMed Web of Science ®Google Scholar
• Fletcher JM, Lonergan R, Costelloe L, et al. CD39 + Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis. J Immunol. 2009;183(11):7602–7610. doi:10.4049/jimmunol.0901881.
   PubMed Web of Science ®Google Scholar
• Jeffries MA. Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy. Clin Immunol. 2018;196:49–58. doi:10.1016/j.clim.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Okada M, Kanamori M, Someya K, et al. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells. Epigenetics Chromatin. 2017;10:24. doi:10.1186/s13072-017-0129-1.
   PubMed Web of Science ®Google Scholar
• Jing W, Zhang X, Sun W, et al. CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells. Biomed Res Int. 2015;2015:1–7. doi:10.1155/2015/326042.
   Google Scholar
• Ewart DT, Peterson EJ, Steer CJ. Gene editing for inflammatory disorders. Ann Rheum Dis. 2019;78(1):6–15. doi:10.1136/annrheumdis-2018-213454.
   PubMed Web of Science ®Google Scholar